Trinity Biotech plc
TRIB
$0.8362
$0.03624.53%
NASDAQ
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.84% | 45.41% | 24.86% | 38.31% | -777.14% |
| Total Depreciation and Amortization | -68.39% | -26.55% | -69.22% | 85.44% | -4.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.92% | -57.01% | -52.37% | -75.54% | 533.55% |
| Change in Net Operating Assets | 229.47% | -18.43% | -1,620.92% | 41.68% | 108.61% |
| Cash from Operations | 75.10% | -86.62% | -789.94% | -128.62% | -60.16% |
| Capital Expenditure | 52.32% | 47.37% | 60.12% | -5.59% | -17.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -649.39% | 3.17% | 24.43% | 75.09% | 40.51% |
| Cash from Investing | -111.37% | 21.64% | 33.08% | 1,647.03% | 32.41% |
| Total Debt Issued | 4,321.09% | -- | -- | -99.27% | -- |
| Total Debt Repaid | 94.33% | 7.00% | 16.52% | 69.79% | 5.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.13% | -2.03% | -10.19% | 45.80% | -- |
| Cash from Financing | 129.10% | -25.87% | -2.49% | -410.98% | -226.72% |
| Foreign Exchange rate Adjustments | -225.58% | -578.79% | 107.82% | 156.21% | -16.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.56% | -280.18% | -149.05% | 2,184.58% | -180.12% |